This inventor holds 1 USPTO granted patent. Top assignee: Starpharma Pty Limited. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Oliver Bernhard: Innovator in Dendrimer-Drug Conjugates
Introduction
Oliver Bernhard is a notable inventor based in Dorfprozelten, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on dendrimer-drug conjugates. His research focuses on the development of macromolecules that can enhance therapeutic applications.
Latest Patents
Oliver Bernhard holds 1 patent related to dendrimer-drug conjugates. This invention pertains to macromolecules that consist of a pharmaceutically active agent, such as a protein or peptide, which is attached to a core of a dendrimer derived from branched building units like lysine or its analogues. The patent also covers the synthesis of these dendrimers and macromolecules, as well as their use in therapeutic applications and pharmaceutical compositions.
Career Highlights
Oliver Bernhard is associated with Starpharma Pty Limited, where he continues to advance his research in dendrimer technology. His work has the potential to revolutionize drug delivery systems and improve patient outcomes in various therapeutic areas.
Collaborations
He collaborates with esteemed colleagues, including David James Owen and Pauline Stanislawski, who contribute to his research endeavors and help in the development of innovative solutions in the pharmaceutical field.
Conclusion
Oliver Bernhard's contributions to dendrimer-drug conjugates exemplify the importance of innovation in the pharmaceutical industry. His work not only enhances drug delivery systems but also paves the way for future advancements in therapeutic applications.